Comparison of high flow nasal cannula and conventional nasal cannula during sedation for endoscopic submucosal dissection: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006618

Enrollment

Registered

2021-09-29

Start date

2021-09-30

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : During endoscopic submucosal resection, the control group receives oxygen using a conventional nasal cannula, and the test group receives oxygen using a high-flow nasal cannula.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA physical status I to III Patients undergoing endoscopic submucosal dissection

Exclusion criteria

Exclusion criteria: - Patients under the age of 18 - Patients requiring oxygen therapy - Patients unable to breathe through the nasal - Patients with severe impaired coagulation profile or who may have nasal bleeding - Patients who have developed or worsened congestive heart failure within the last 6 months - Patients with increased intracranial pressure - Patients with ASA class IV or higher - Patients with unstable hemodynamics - Patients with a history of pneumothorax - Patients with oral and nasal infections - Pregnant or lactating women - Patients who do not understand this study and who refuse the study - Patients with a history of serious psychological disease

Design outcomes

Primary

Measure	Time frame
lowest oxygen saturation	—

Secondary

Measure	Time frame
Hypoxia(SpO2=60) and duration of time;Procedural interruption for increased saturation(jaw thrust, Patient stimulation, increase oxygen flow, dose adjustment, ,nasal airway insertion, ambu bagging, LMA insertion);adverse effect (Xeromycteria, Rhinalgia);operator satisfaction (1-5);mean of oxygen saturation;Post procedure chest X-ray ;Whether oxygen is administered when leaving the recovery room;First oxygen saturation after oxygen ceased in recovery room;First oxygen saturation after arrival at the ward;Whether to maintain oxygen administration after arrival at the ward;PtCO2 value;incidence of SpO2 < 95	—

Measure

Time frame

Hypoxia(SpO2=60) and duration of time;Procedural interruption for increased saturation(jaw thrust, Patient stimulation, increase oxygen flow, dose adjustment, ,nasal airway insertion, ambu bagging, LMA insertion);adverse effect (Xeromycteria, Rhinalgia);operator satisfaction (1-5);mean of oxygen saturation;Post procedure chest X-ray ;Whether oxygen is administered when leaving the recovery room;First oxygen saturation after oxygen ceased in recovery room;First oxygen saturation after arrival at the ward;Whether to maintain oxygen administration after arrival at the ward;PtCO2 value;incidence of SpO2 < 95

—

Countries

Korea, Republic of

Contacts

Public ContactJoan Seungwon Lee

Samsung Medical Center

seungwon0209.lee@samsung.com+82-2-3410-0369

Outcome results